2016/02/02 22:58 
主訴(Chief Complaint) 
Informant:patient's wife
new stroke (right upper limb weakness) for 1 day 
病史(Brief History) 
This 68-year-old man has past history of:
1. IHCA status post CPR and ECMO due to cardiovascular disease(3-vessel-disease with NSTEMI), status post CABG on 2011/12/28
2. Chronic kidney injury for 17~18 years with OPD follow-up
3. Hypertension for 10+ years, under medication control 
4. Type 2 diabetes mellitus for 10+ years, under medication control
5. Left lower limb status post above knee amputation  due to peripheral arterial occlusive disease in 2012/2 
6. Old infarctions at left posteior frontal and parietal cortical/subcortical regions (2013 MRI)

   At baseline, he could walk with quadricane slowly (with 左下肢義肢), and communicate freely. As for his CVD, he was under DAPT(Bokey+Plavix), and shifted to Plavix only since 2015/12/25 due side effect of GI upset.
   According to the patient's statement, he had slurred speech and right limbs waekness after woke up on 2015/12/29 morning. He also had nausea/vomiting, headache over the occipital region, vertigo, and blurred vision. Besides, there were drooling and cholking when eating. The symptoms was not so severe that bothered him very much(still able to walk with quadricane), thus, he neglected them. However, after 2 days on 2015/12/31, he could barely stand up so that he came to our ER for help.  
   At ER, the BP was 178/100mmHg. Brain noncontrast CT on 2015/12/31 showed old infarct in left posterior frontal and parietal lobes, as well as lacunar infarcts in bilateral perinventricular white matter. Brain MRI on 2015/12/31 revealed (1)Recent infarction at right paramedian pons, (2)Brain atrophy, leukoaraiosis and multiple old insults, (3)Diffuse atherosclerotic narrowing of cervicocranial vessels. He was admitted to geriatric ward on 2016/01/04 for further treatment for ischemic stroke. Hydration with normal saline 1000ml QD was given and antihypertensive drug was hold. Bokey was added and shifted back to DAPT. Physical therapy started and Foley was removed on 01/07 and oral feeding started on 01/08. Due to stable condition of acute ischemic stroke in right paramedian pons, he was admitted to PM&R ward for rehabilitation program on 01/12. 
   Pus-like discharge from right 3rd toe was noted on 01/15, r/o progression of PAOD in his right leg. There was no pulsation of anterior tibialis and dorsalis pedis artery. Vascular sonography revealed no blood flow at right anterior tibial artery. Bokey+ Plavix was shifted to Pletaal+ Plavix for PAOD. Right foot pain was controlled with Ultracet. Besides, Augmentin 1tab QD was given for wound infection since 01/18. 01/19 Wound culture revealed Enterobacter cloacae 3+ and Pseudomonas aeruginosa 3+. Antibotics was changed to Tatumcef on 01/22 according to susceptibility test and elevated CRP.
   Poor coperation, general weakness, poor oral intake with aspiration was noted on 01/22. Fever with dyspnea developed on 01/23. CXR also showed mild increased infiltration at bilateral lower lung fields. Tazocin was given as empirical antibiotics. NG was also inserted because of poor oral intake. Sublingual NTG had been used for chest tightness. Antibiotics was then changed to Maxipime on 01/26 due to susceptability test. Stool WBC was negative. No fever or dyspnea was noticed after 01/24. Productive cough also improved. Because of poor peripheral intravenous line, CVC was inserted on 01/25.
   However, poor oral intake, right side weakness, and inconsistency in following order persisted after infection contol. Therefore, emergent brain MRI was arranged on 2016/01/28 for suspected stroke in evolution, showing multiple recent infarction at the left frontal periventricular white matter, bilateral cerebellum, and posterior pons. Antihypertensive agents were held and hydration was given. Cardiac echo on 02/01 revealed regional wall motion abnormalities, impaired LV relaxation, mild MR/TR/AR, mild decreased LVEF (59.7%).
   Acute onset of AfRVR with dyspnea was noted on 2016/1/29, initially electrolyte imbalance or infection was suspected. Codarone was given for rhythm/rate control and empirical Maxipime was given. However, massive abdominal ascites developed and the patient underwent 3 times of paracentesis. The ascites was milky, with minimal cell cound and protein content. No elevation of TG or decrease of ascites glucose was noticed. Abdominal/Pelvis CT was done, showing suspectious fat stranding in the upper abdomen, r/o peritontiis. Infection specialist was consulted and suggested shifting abx to Mepem for better converage of ESBL. Also, elevation in BUN/Creatinine levels, CRP, leukocytosis with left shift were also noticed. Further workups showed ProBNP 20000pg/mL, AntiHCV positive. Cardiologist was consult for tachycardia under Codarone use. Multifocal atrial tachycardia was suspected. 24hrs holter was arranged and Verapamil was given for rate control. 
   On 2016/2/1, he was last reported normal (Bilateral UE MP>3, Brunnstrom stage > III/III) at 2016/2/1 18:00. During 18:00-22:00, right side hemiplegia developed with persistent left side gaze. Another acute episode of left side stroke was highly suspected, emergent CT showed no ICH, and new infarcts in left frontal lobe and left cerebellum. The family refused to proceed to CTA->IA due to the risk of hemodialysis. Neck CVC was inserted on 02/01 for monitoring CVP level, goal 7-12cm, with cautious hydration. Due to suspected new recurrent stroke, ACKD condition (CCr=16) and bleeding risk and uncertain for previous suspected atrial fibrillation diagnosis, anticoagulation was not indicated for now. TCD/Dupplex on 02/01 revealed 1.Mild to moderate atherosclerosis in bilateral CCAs, carotid bulbs, and left ICA. 2.Left VA stenosis or hypoplasia with inadequate total VA flow amount. 3. right MCA, left PCA, right VA stenosis.
   Further brain image would be arranged for new onset right side hemiparesis to rule out recurrent stroke. The family (Key person: 女兒) prefered palliative/conservative therapy and signed DNR. Under the impression of recurrent stroke, occult infection, heart failure, ascited of unknown origin and ACKD, he was admitted to geriatric ward for further management.

Family History: no systemic underlying disease
Medication Allergy:No  病人自述 2016/01/12
No  親屬描述 2016/01/04
No  病人自述 2016/01/12
No  病人自述 2016/01/12
UnClear  病人自述 2011/12/21
Medication ADR:unknown
Allergy to Medical Device and Materials:No  病人自述 2016/01/12
No  病人自述 2016/01/12
No  親屬描述 2016/01/04
No  病人自述 2016/01/12
Current Medication:
NTUH:Plavix 75 mg/tab 1 tab QD PO 5 days
Takepron OD 30 mg/tab 1 tab QDAC LZ 4 days
Dulcolax EC 5 mg/tab 1 tab HS PO 3 days
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 3 days
栓 Bisacodyl Supp 10 mg/pill 2 pill STAT R 1 days
Glucobay 50 mg/tab 1 tab TID POMEAL 28 days
警 Lantus SoloStar 300 IU/3 mL /pen 14 IU AS ORDER SC 28 days
(8mm) Micro-Fine Insulin Pen Needle 31G /set 1 set QD SC 28 days
NovoNorm 1 mg/tab 0.5 tab TIDAC15 PO 28 days
Lasix 40 mg/tab 1 tab BID PO 28 days
Aldactone 25 mg/tab 1 tab BID PO 28 days
6.25 DILATREND 6.25 mg/tab 1 tab QD PO 28 days
HARNALIDGE D 0.2 mg/tab 2 tab HS LZ 28 days
Norvasc 5 mg/tab 1 tab QD PO 28 days
Plavix 75 mg/tab 1 tab QD PO 28 days
Bethanechol 25 mg/tab 1 tab BID PO 28 days
(管4) 安柏寧 Alpraline 0.5 mg/tab 1 tab HS PO 28 days
Other: nil 
中草藥: nil 
保健食品: nil 

Past Medical History:
1. IHCA status post CPR and ECMO due to cardiovascular disease(3-vessel-disease with NSTEMI), status post CABG on 2011/12/28
2. Chronic kidney injury for 17~18 years with OPD follow-up
3. Hypertension for 10+ years, under medication control 
4. Type 2 diabetes mellitus for 10+ years, under medication control
5. Left lower limb status post above knee amputation  due to peripheral arterial occlusive disease in 2012/2 
6. Old infarctions at left posteior frontal and parietal cortical/subcortical regions (2013 MRI)

Hospitalization:
1. 1999,nephrotic syndrome
2. IHCA status post CPR and ECMO due to cardiovascular disease(3-vessel-disease with NSTEMI), status post CABG on 2011/12/28
3. Left lower limb status post above knee amputation  due to peripheral arterial occlusive disease in 2012/2

Past Surgical History:
1. IHCA status post CPR and ECMO due to cardiovascular disease(3-vessel-disease with NSTEMI), status post CABG on 2011/12/28
2. Left lower limb status post above knee amputation  due to peripheral arterial occlusive disease in 2012/2

Travel History: nil 
社會心理相關評估(Psychosocial Assessment) 
Social Economic and Personal History
教育程度:小學
職業:退休
宗教信仰:道教
婚姻狀態:已婚
使用語言:國語 台語 
口述血型:B，RH:不清楚，輸血反應:沒輸過血
抽煙:沒有
喝酒:沒有
檳榔:沒有
物質濫用:

Psychological History and Evaluation
意識狀態:混淆
認知功能:無法評估 
精神情緒狀態:異常 倦怠 情緒低落 
安全問題:有 其他 跌倒
睡眠形態:異常 入睡困難 淺、易醒 使用藥物 

Nutritional Screen
攝食情形:優，攝取完整
排便狀態:異常
排便異常狀態:腹瀉
BMI:20.9

Fall Risk Assessment
總分:14
(>=3分進行不倒翁計畫，請開預防跌倒醫囑) 
系統性回顧(Review of System) 
1.Systemic: weight loss(-), easy-fatigability(+), night sweats(-)
2.Skin:  petechiae(-), purpurae(-), skin rash(-), itching(-),
3.HEENT: headache(-),dizziness(-), blurred vision(-), strabismus(-), ocular pain(-), otalgia(-), otorrhea(-), hearing impairment(-), tinnitus(-), vertigo(-), nasal stuffiness(-), nasal discharge(-) , epistaxis(-), gum bleeding(-), sore throat(-),oral ulcer(-)
4.Cardiovascular:  exertional chest tightness(-), nocturnal dyspnea(-), orthopnea(-) syncope(-), palpitation(-), intermittent claudication(+) due to PAOD in right leg 
5.Respiratory: dyspnea on exertion(-), cough(-), chest pain(-), hemoptysis(-), productive cough (-), pleuritic chest pain(-)
6.GI: anorexia(-), nausea(-), vomiting(-), dysphagia(-), heart burn(-), acid regurgitation(-), abdominal fullness(-), hunger pain(-) midnight pain(-), constipation(-), diarrhea(-), melena(-), change of bowel habit(-), small caliber of stool(-), tenesmus(-), flatulence(-)
7.Urogenital: flank pain(-), hematuria(-), urinary frequency(-), urgency(-), dysuria (-), hesitancy(-), small stream of urine(-), impotence(-), nocturia(-), polyuria(-), oliguria (-)
8.Musculoskeletal: bone pain(-), arthralgia(-), myalgia(-), back pain(-)
9.Metabolic: heat intolerance(-), cold intolerance(-), thirsty(-)
10.Nervous: numbness (+)right hemiparesis hemiplegia (-) 
身體檢查(Physical Examination) 
BH:165 cm   BW:56.9 kg
T:36.5 P:116 R:32
BP:173/80 mmHg
Pain:0

Neurological Examination:
Consciousness: E4V2M5-6, unable to answer name or respond to verbal orders correctly, disoriented and suspected delirious
NIHSS=15+x (02102103x201120, right hemianopia+right hemiparesis+severe dysarthria+language, old score:right hypoesthesia+right hemiparesis, lower leg+right shallower naso-labial fold)
CN II:light reflex +/+, 2mm/2mm, right hemianopia as by threatening test
CN III, IV, VI:could not follow verbal orders for EOM testing, no preferential gaze noted during NE examination, OCR correctable without specific liimitation
CN V:bilateral facial grimace, weaker on the right side
CN VII:right side shallower nasolabial fold
CN IX, X:unable to test due to patient's incooperative state

Muscle power:
RUL: 2 for proximal to pain stimulation RLL >3 to pain stimulation
LUL: >4 could raise by spontaneous movement LLL:status post above knee amputation, stump >3

DTR
Right bicep +++ tricep ++ brachiordialis ++ knee ++ ankle ++
Left bicep ++ tricep ++ brachioradialis ++ knee and ankle is amputated and unevaluable

Babinski:
Right:withdrawal
Left:status post above knee amputation

Sensation:bilateral grimace to pain stimulation at bilateral upper limb and right lower limb, but weaker on the right side
FNF:unable to perform

HEENT: conjunctivae: pale, sclerae: anicteric, pupils: isocoric 3/3mm, light reflex +/+, 
Throat injection (-), tonsil enlarge (-), oral ulcer or thrush (-) 
Neck: supple, no stiffness, no jugular vein engorgement, no goiter
Chest: Symmetric expansion, deformity (-), tactile fremitus (-), subcostal retraction (-),suprasternal retraction (-), breath sounds: clear, no crackles
Heart: regular heart beats, no audible murmur/gallop/friction rub
Abdomen: soft and flat, bowel sound: normoactive. no tenderness. 
Extremities: 
 Right leg(below 1/2 tibia): redness(+), coldness(+), pain(-), swelling(+)mild, suspect edema, dorsalis pedis pulsation(-), popliteal pulsation(+), 4th toe: dry gangrene
 Left leg: above knee amputation 
檢驗紀錄(Laboratory Report) 
*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1050105 [0415] 142          
1050106 [1716] 299          
1050106 [2244] 127          
1050107 [0511] 104          
1050107 [1139] 188          
1050107 [1813] 192          
1050107 [2155] 192          
1050108 [0414] 95           
1050108 [1021] 299          
1050108 [1813] 153          
1050108 [2216] 142          
1050109 [0519] 109          
1050109 [1124] 189          
1050109 [1805] 175          
1050109 [2157] 259          
1050110 [0526] 102          
1050110 [1201] 206          
1050110 [1804] 209          
1050110 [2206] 242          
1050111 [0457] 114          
1050111 [1129] 193          
1050111 [1807] 190          
1050112 [0432] 140          
1050112 [1457] 136          
1050113 [0532] 108          
1050113 [1821] 169          
1050114 [0531] 82           
1050114 [1651] 127          
1050115 [0619] 91           
1050115 [1617] 175          
1050116 [0554] 83           
1050116 [1625] 155          
1050117 [0524] 87           
1050117 [1611] 113          
1050118 [0557] 86           
1050118 [1622] 137          
1050119 [0555] 89           
1050119 [1626] 150          
1050120 [0537] 101          
1050120 [1650] 92           
1050121 [0547] 69           
1050121 [1624] 112          
1050122 [0549] 66           
1050122 [1012] 178          
1050122 [1619] 258          
1050123 [0542] 89           
1050123 [1732] 319          
1050124 [0558] 140          
1050124 [1641] 242          
1050125 [0551] 159          
1050125 [1636] 319          
1050126 [0533] 125          
1050126 [1611] 289          
1050127 [0534] 178          
1050127 [1622] 320          
1050128 [0544] 171          
1050128 [1659] 379          
1050129 [0548] 192          
1050129 [1537] 402          
1050129 [2058] 327          
1050130 [0202] 212          
1050130 [0704] 328          
1050130 [1211] 390          
1050130 [1625] 476          
1050130 [2047] 488          
1050131 [0602] 266          
1050131 [1104] 429          
1050131 [1614] 446          
1050131 [2133] 386          
1050201 [0609] 256          
1050201 [1101] 457          
1050201 [1603] 538          
1050201 [2119] 539          
1050202 [0626] 273          
1050202 [1123] 303          

*********檢驗室:B3***********
B3-1050119-8005860   OTHER DISCHARGE
     ID+DS Common #1:       Enterobacter cloacae 3+
     ID+DS Common #2:       Pseudomonas aeruginosa 3+
     Anaerobic #1:       No anaerobic pathogen
B3-1050201-1063288   SPUTUM (EXPECTORATED)
     Gram's(GS)#1:       Few PMNs ( <10 /LPF )
     Gram's(GS)#2:       Moderate epithelial cells ( 10-25 /LPF )
     Gram's(GS)#3:       Gram (+) cocci in chains 3+
     ID+DS Sputum Culture #1:       Mixed flora
     Gram's(GS)#4:       Gram (+) cocci in cluster,  Yeast-like organism 1+
     Gram's(GS)#5:       痰檢體品質不良建議重新送檢,  Gram (-) rods 2+
B3-1050123-3010163   SPUTUM (EXPECTORATED)
     Gram's(GS)#1:       Many PMNs ( >25 /LPF )
     Gram's(GS)#2:       Many epithelial cells ( >25 /LPF )
     Gram's(GS)#3:       Yeast-like organism 3+
     ID+DS Sputum Culture #1:       Mixed flora
     Gram's(GS)#4:       Gram (+) rods 1+
     Gram's(GS)#5:       痰檢體品質不良建議重新送檢,  Gram (-) rods 1+
B3-1050106-6088923   SKIN PUS
     ID+DS Common #1:       Coagulase neg. staphylococci 1+
     Anaerobic #1:       No anaerobic pathogen
B3-1050130-0031270   ASCITES
     ID+DS Common #1:       No aerobic  pathogen

*********檢驗室:RL***********

群組:Biochemistry

               BUN           CRE           Na            K             Ammonia N    
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)      (μmol/L)     
1050122 [1430] 29.8          2.8           135           3.9                        
1050125 [0552] 31.9          2.9           141           3.0                        
1050129 [0550] 35.5          3.0           139           2.9                        
1050129 [2003]                                           3.3                        
1050129 [2053] 38.9          3.0           135           3.4                        
1050130 [2247]                                                         15           
1050131 [0614] 35.2          3.0           140           2.9                        
1050131 [1828]                                                                      
1050131 [2051]                                                                      
1050201 [0610] 33.5          3.1           140           2.8                        
1050202 [0238] 38.7          3.6           138           3.2                        
               T-BIL         AMY           Lipase        Ca            Mg           
time/item      (mg/dL)       (U/L)         (U/L)         (mmol/L)      (mmol/L)     
1050122 [1430]                                                                      
1050125 [0552]                                                                      
1050129 [0550]                                                                      
1050129 [2003]                                                                      
1050129 [2053]                                           1.70          0.70         
1050130 [2247]                                                                      
1050131 [0614]               50            96            1.81          0.87         
1050131 [1828]                                                                      
1050131 [2051]               31                                                     
1050201 [0610] 0.35                                                    0.77         
1050202 [0238]                                           1.87          1.58         
               AST           LacticAcid    CK            Troponin I   
time/item      (U/L)         (mmol/L)      (U/L)         (ng/mL)      
1050122 [1430]                             127           0.051        
1050125 [0552]                                                        
1050129 [0550]                                                        
1050129 [2003]                             76            0.103        
1050129 [2053]                                                        
1050130 [2247]               1.55                                     
1050131 [0614] 26                          51            0.226        
1050131 [1828]                             60            0.158        
1050131 [2051]                                                        
1050201 [0610] 29                                                     
1050202 [0238]                                                        
群組:

               CK-MB        
time/item      (ng/mL)      
1050122 [1430] 4.05         
1050129 [2003] 4.61         
1050131 [0614] 3.63         
1050131 [1828] 4.47         
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050122 [1430] 10.92         3.46          10.8          31.9          92.2         
1050125 [0552] 8.94          3.22          9.8           28.8          89.4         
1050129 [0550] 12.97         3.18          9.7           27.9          87.7         
1050201 [0610] 11.74         2.90          8.8           25.1          86.6         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1050122 [1430] 31.2          33.9          188           14.4          -            
1050125 [0552] 30.4          34.0          168           13.8          -            
1050129 [0550] 30.5          34.8          189           14.3          -            
1050201 [0610] 30.3          35.1          213           14.6          -            
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050122 [1430] 0.0           0.0           0.0           0.0           0.0          
1050125 [0552] 0.0           0.0           0.0           0.0           0.0          
1050129 [0550] 0.0           0.0           0.0           0.0           0.0          
1050201 [0610] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050122 [1430] 81.4          4.9           0.5           6.1           7.1          
1050125 [0552] 79.5          3.5           0.4           7.4           9.2          
1050129 [0550] 80.3          1.3           0.2           8.0           10.2         
1050201 [0610] 82.6          0.8           0.1           6.6           9.9          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050122 [1430] 0.0           0.0           0             -            
1050125 [0552] 0.0           0.0           0             -            
1050129 [0550] 0.0           0.0           0             -            
1050201 [0610] 0.0           0.0           0             -            
群組:General BioChemistry

               TG            TP            ALB           ALT           ALP          
time/item      (mg/dL)       (g/dL)        (g/dL)        (U/L)         (U/L)        
1050122 [1430]                                           17                         
1050125 [0552]                                           17                         
1050129 [0550]                                           27                         
1050129 [2053]                                           27                         
1050129 [2355]                             2.0                                      
1050131 [0614]               4.5           2.1                                      
1050131 [2051] 48            <3.0          <1.5                        <5           
1050201 [0610]                                           23                         
               LDH          
time/item      (U/L)        
1050122 [1430]              
1050125 [0552]              
1050129 [0550]              
1050129 [2053]              
1050129 [2355]              
1050131 [0614] 198          
1050131 [2051]              
1050201 [0610]              
群組:Yes

               C-Reactive P  hsCRP         D-Dimer       FDP           Fibrinogen   
               rotein                                                               
time/item      (mg/dL)       (mg/dL)       (μg/mL FEU)   (μg/mL)       (mg/dL)      
1050122 [1430] 7.00                                                                 
1050125 [0552] 6.82                                                                 
1050129 [0550]               3.80                                                   
1050129 [2053]               5.13                                                   
1050129 [2315]                             6.61          21.2          491.0        
1050131 [1847]                                                                      
1050201 [0610]               4.89                                                   
               NT-pro BNP   
time/item      (pg/mL)      
1050122 [1430]              
1050125 [0552]              
1050129 [0550]              
1050129 [2053]              
1050129 [2315]              
1050131 [1847] 20000        
1050201 [0610]              
群組:Blood pH/Gas

               PH            PCO2          PO2           HCO3          BaseExcess   
time/item      (*)           (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1050129 [2003] 7.402         19.8          114.6         12.4          -12.6        
1050130 [2247] 7.355         25.4          39.6          14.3          -11.5        
1050131 [0614] 7.382         26.2          41.3          15.7          -9.7         
1050202 [0238] 7.373         24.1          42.0          14.2          -11.3        
群組:Punctate Exam.

               Sp. gr.       Rivalta's Te  Total nuclea  RBC count     Sediment-Eos 
                             st            r cell count                in           
                                          (TNC)                                    
time/item      (*)           (*)           (/μL)         (/μL)         (%)          
1050131 [2051] 1.009         -             114           <3000         0            
               Sediment-Lym  Sediment-M&H  Sediment-Neu  Sediment-Not                                           
                                                       e            
time/item      (%)           (%)           (%)           (*)          
1050131 [2051] 90            8             2             N/A          
*********檢驗室:OP***********

群組:SEDIMENT

               RBC (S)       WBC (S)       Epith (S)     Cast (S)      Crystal (S)  
time/item      (/HPF)        (/HPF)        (/HPF)        (/LPF)        (*)          
1050122 [1437] 0-2           2-5           5-10          Hy(2-5) Gr(5  -            
                                                       -10) Cellula               
                                                       r(0-2)                     
1050201 [1329] 2-5           5-10          2-5           Hy(2-5) Gr(0  -            
                                                       -2) Waxy(0-2               
                                                       )                          
               Bacteria      Mucus(S)      Others (S)   
time/item      (*)           (*)           (*)          
1050122 [1437] 2+            -             Yeast(2+)    
1050201 [1329] +             -             -            
群組:MULTISTIX

               Sp. Gr.(C)    pH            Protein(C)    Glu.(C)       Ketone body  
                                                                    (U)          
time/item      (*)           (*)           (mg/dL)       (mg/dL)       (*)          
1050122 [1437] 1.018         6.5           600 ( 3+ )    >1000 ( 4+ )  -                          
1050201 [1329] 1.026         6.5           600 ( 3+ )    >1000 ( 4+ )  -                          
               O.B.(C)       Urobil.(C)    Bil.(C)       Nitrite(C)    WBC esterase 
                                                                     (U)         
time/item      (*)           (mg/dL)       (*)           (*)           (*)          
1050122 [1437] 1+            ≦1.5          -             -             -            
1050201 [1329] 2+            ≦1.5          -             -             -            
               Color         Turbidity    
time/item      (*)           (*)          
1050122 [1437] Yellow        -            
1050201 [1329] Yellow        -            
群組:STOOL

               O.B.          Stool WBC    
time/item      (*)           (/HPF)       
1050126 [1003]               Not found    
1050129 [1212] 2+                         
群組:Punctate Exam.

               Sp. Gr.(A)    Rivalta's(A)  Total nuclea  RBC count     Sediment-Eos               
                                          r cell count                in           
                                          (TNC)                                    
time/item      (*)           (*)           (/μL)         (/μL)         (%)          
1050130 [0123] 1.008         -             26            <3000         N/A          
1050131 [0432] 1.009         +             71            <3000         0            
               Sediment-Lym  Sediment-M&H  Sediment-Neu  Sediment-Not                                           
                                                       e            
time/item      (%)           (%)           (%)           (*)          
1050130 [0123] N/A           N/A           N/A           Damaged Cell               
1050131 [0432] 62            38            0             N/A          
*********檢驗室:BC***********

群組:Others

               Osmolality(B  Osmolality(U 
               )             )            
time/item      (mOsm/Kg)     (mOsm/Kg)    
1050201 [2044] 324           408          
群組:General BioChemistry

               Alb           TP            T-BIL         ALT           GGT          
time/item      (g/dL)        (g/dL)        (mg/dL)       (U/L)         (U/L)        
1050108 [0612]                                           41                         
1050130 [0123] <1.5          <3.0                                                   
1050130 [0711]                             0.26                        109          
1050131 [0432] <1.5          <3.0                                                   
1050131 [0718]                                                                      
1050131 [2051]                                                                      
1050201 [0610]                                                                      
1050201 [2044]                                                                      
               LDH           UN            CRE           Na            K(U)         
time/item      (U/L)         (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)     
1050108 [0612]               30.3          2.3           135                        
1050130 [0123] <25                                                                  
1050130 [0711]               37.3          2.9           137                        
1050131 [0432] <25                                                                  
1050131 [0718]                                                                      
1050131 [2051] 25                                                                   
1050201 [0610]                                                                      
1050201 [2044]                                                         34           
               K             Mg            TG            T-CHO         HDL-C        
time/item      (mmol/L)      (mmol/L)      (mg/dL)       (mg/dL)       (mg/dL)      
1050108 [0612] 3.8                                                                  
1050130 [0123]                                                                      
1050130 [0711] 3.3           0.78                                                   
1050131 [0432]                                                                      
1050131 [0718]                             51                                       
1050131 [2051]                                                                      
1050201 [0610]                             173           126           18           
1050201 [2044]                                                                      
群組:DM

               GLU AC        HbA1c        
time/item      (mg/dL)       (%)          
1050129 [0550]               6.8          
1050131 [0432] 515                        
1050131 [2051] 436                        
群組:Hormones

               Free T4(CIA)  hsTSH(CIA)    Cortisol DL   ACTH                       
time/item      (ng/dL)       (μIU/mL)      (μg/dL)       (pg/mL)      
1050201 [0610] 1.05                                                   
1050201 [0814]               1.09          24.4          33.7         
*********檢驗室:HE***********

群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (k/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1050108 [0612] 8.89          3.35          10.4          30.7          91.6         
1050130 [0711] 14.07         3.11          9.6           27.7          89.1         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (k/μL)        (%)           ()           
1050108 [0612] 31.0          33.9          171           14.0          -            
1050130 [0711] 30.9          34.7          212           14.6          -            
群組:WBC D/C

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1050108 [0612] 0.0           0.0           0.0           0.0           0.0          
1050130 [0711] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1050108 [0612] 78.8          4.9           0.4           9.3           6.6          
1050130 [0711] 86.0          0.9           0.1           8.2           4.8          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1050108 [0612] 0.0           0.0           0             -            
1050130 [0711] 0.0           0.0           0             -            

*********檢驗室:B2***********
B2-1050122-2097557   BLOOD
     ID+DS Blood.#1:       No growth after 5 days


*********檢驗室:B4***********
B4-1050130-0031271   ASCITES
     AF Stain(AF) #1:       Acid fast bacilli - negative

*********檢驗室:CT***********

群組:PT

               PT            PT INR       
time/item      (sec)         ()           
1050130 [0711] 10.4          0.98         
群組:PTT

               PTT          
time/item      (sec)        
1050130 [0711] 28.3         
*********檢驗室:N2***********

群組:Tumor Marker

               RIA:CEA (Tis 
               sue Fluid)   
time/item      (ng/ml)      
1050131 [2051] 1.45         
*********檢驗室:SF***********

群組:Yes

               Anti-HCV Ab   HBsAg        
time/item      (*)           (IU/mL)      
1050201 [0610] Positive      Negative(0.0 
                             0)           


*********檢驗室:B3***********
B3-1041225-5016291   SKIN PUS
     ID+DS Common #1:       Enterobacter cloacae 2+
     ID+DS Common #2:       Staphylococcus aureus 2+
     Anaerobic #1:       No anaerobic pathogen


*********檢驗室:RL***********

群組:Biochemistry

               BUN           CRE           Na            K            
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)     
1041231 [1507] 35.6          3.8           133           4.3          
1050103 [0527] 35.8          2.9           136           4.0          
1050104 [0606] 34.3          2.8           134           4.0          
群組:Coagulation

               PT            PTT           PT INR       
time/item      (sec)         (sec)         ()           
1041231 [1507] 9.6           20.5          0.90         
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1041231 [1507] 68           
1050103 [0527] 47           
1050104 [0606] 42           
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1041231 [1514] 7.82          3.34          10.7          30.8          92.2         
1050103 [0527] 7.69          3.58          11.4          33.5          93.6         
1050104 [0655] 8.22          3.35          10.4          30.3          90.4         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1041231 [1514] 32.0          34.7          180           14.1          -            
1050103 [0527] 31.8          34.0          148           14.2          -            
1050104 [0655] 31.0          34.3          157           14.0          -            
*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1041231 [1509] 192          
1050101 [1331] 95           
1050101 [1753] 86           
1050101 [2034] 144          
1050102 [0449] 125          
1050102 [1206] 258          
1050102 [1706] 135          
1050102 [2014] 210          
1050103 [0525] 108          
1050103 [1255] 163          
1050103 [1657] 230          
1050103 [2037] 210          
1050104 [0608] 137          
1050104 [1203] 199          
1050104 [1634] 190          
*********檢驗室:RL***********

群組:Biochemistry

               BUN           CRE           Na            K             Ca           
time/item      (mg/dL)       (mg/dL)       (mmol/L)      (mmol/L)      (mmol/L)     
1041228 [1128] 40.7          2.9           132           5.1           2.05         
               Troponin I   
time/item      (ng/mL)      
1041228 [1128] 0.051        
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1041228 [1128] 48           
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1041228 [1128] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1041228 [1128] 85.7          2.3           0.6           4.6           6.8          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1041228 [1128] 0.0           0.0           0             -            
群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1041228 [1128] 8.94          3.74          11.8          34.2          91.4         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1041228 [1128] 31.6          34.5          177           14.5          -            
*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1041228 [1128] 193 
檢查紀錄(Examination Report) 
nil 
影像報告(Imaging Report) 
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 施怡倫 影像時間: 2016/02/01 15:30 (32001CYM) 發報告時間: 2016/02/01 16:34 EXAMINATION: Chest : AP View (Supine)
FINDINGS:
Placement of a NG tube and a right central venous catheter. Sternal wiring. Normal heart size. Increased infiltration over bilateral lungs. Previous fractures of the left clavicle and ribs.
CT Without Contrast-Brain 醫令: CT Without Contrast-Brain 報告醫師: 李崇維 影像時間: 2016/02/01 23:57 (33070B0M) 發報告時間: 2016/02/02 09:54 MRI of the brain without and with i.v. Gd chelate enhancement shows:
1. Multiple low-density patches in left fronto-parietal lobe, bilateral periventricular white matter, bilateral cerebellum. Left upper cerebellar lesion and left frontal cortical lesion are new. 
2. Prominent sulci and fissures.
3. No definite acute intracranial hemorrhage. 
4. Ill-defined low-density patches at periventricular white matter. 
5. No definite focal lesion in the cranial vault.
CT Without Contrast-Pelvis 醫令: CT Without Contrast-Pelvis 報告醫師: 李鼎專 影像時間: 2016/01/31 02:23 (33070B5M) 發報告時間: 2016/02/01 12:09 CT of abdomen and pelvis without contrast shows: 
(The sensitivity and specificity of non-contrast study are limited.) 
1. increased ascites and mesenteric fat stranding, more severe at upper abdomen. 
2. parenchymal liver disease.
3. no obvious focal lesion is noted at pancreas, spleen, bilateral kidneys and adrenal glands. 
4. small paraaortic lymph nodes. 
5. s/p NG tube insertion. s/p foley insertion. 
6. left inguinal hernia. 
7. left pleural effusion with atelectasis of LLL. Small right pleural effusion. 
8. atherosclerotic change of aorta and coronary arteries. Metallic wiring of sternum. 
9. thoracolumbar spondylosis with degenerative marginal spurs. Old left rib fractures.
CT Without Contrast-Abdomen 醫令: CT Without Contrast-Abdomen 報告醫師: 李鼎專 影像時間: 2016/01/31 02:23 (33070B3M) 發報告時間: 2016/02/01 12:09 CT of abdomen and pelvis without contrast shows: 
(The sensitivity and specificity of non-contrast study are limited.) 
1. increased ascites and mesenteric fat stranding, more severe at upper abdomen. 
2. parenchymal liver disease.
3. no obvious focal lesion is noted at pancreas, spleen, bilateral kidneys and adrenal glands. 
4. small paraaortic lymph nodes. 
5. s/p NG tube insertion. s/p foley insertion. 
6. left inguinal hernia. 
7. left pleural effusion with atelectasis of LLL. Small right pleural effusion. 
8. atherosclerotic change of aorta and coronary arteries. Metallic wiring of sternum. 
9. thoracolumbar spondylosis with degenerative marginal spurs. Old left rib fractures.
CT With/Without Contrast-Chest 醫令: CT With/Without Contrast-Chest 報告醫師: 張為迪 影像時間: 2016/01/29 23:43 (33072B2M) 發報告時間: 2016/02/01 13:08 CT of the chest without and with contrast enhancement shows: 
> Status post CABG with sternal wiring.
> Atherosclerotic change with mural calcification of the aorta and coronary arteries.
> Status post nasogastric tube insertion.
> An ill-defined partsolid opacity about 1.2m at the RUL (SE5 IM101). Subsegmental atelectasis at the RML, lingular LUL, and bilateral lower lobes.
> Bilateral pleural effusion. 
> Small bilateral mediastinal lymph nodes. 
> No definite focal lesion in bilateral adrenals. 
> Small bilateral renal cysts. 
> Gall stone(s). 
> Small paraaortic lymph nodes.
> Moderate ascites.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 柯維鈞 影像時間: 2016/01/29 21:09 (32001CYM) 發報告時間: 2016/01/31 16:56 Chest AP shows postoperative change with thoracotomy and placement of multiple sternal wires. placement of a NG tube. normal heart size. tortuous aorta. hazy opacities at both lungs. elevated right hemidiaphragm. degenerative change of the T spine. obscured bilateral costophrenic angles.
MRI Without Contrast--Brain 醫令: MRI Without Contrast--Brain 報告醫師: 李崇維 影像時間: 2016/01/28 21:15 (33084B0M) 發報告時間: 2016/01/29 12:00 MRI of the brain without contrast enhancement shows:
> Multiple recent infarction at the left frontal periventricular white matter, bilateral cerebellum, posterior pons.
> Brain atrophy.
> Old insult at the left parietal lobe. Atrophy of the right pons.
> Multiple stenosis at left MCA, left ICA, BA and bilateral VA.
> Intact cranial vault.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 李怡範 影像時間: 2016/01/23 17:49 (32001CYM) 發報告時間: 2016/01/26 08:47 normal heart size. tortuous aorta with calcification. placement of multiple sternal wires. bilateral lung opacities. left pleural effusion.
Abdomen:KUB 醫令: Abdomen:KUB 報告醫師: 簡寧 影像時間: 2016/01/03 12:00 (32006C0M) 發報告時間: 2016/01/03 23:20 unremarkable bowel gas pattern. phlebolith(s) in the pelvic cavity. a calcified stone superimposed in the LUQ of abdomen. spondylosis of the spine with marginal spur formation of the lumbar spine. placement of a NG tube.
Chest : AP View (Supine) 醫令: Chest : AP View (Supine) 報告醫師: 簡寧 影像時間: 2016/01/03 11:59 (32001CYM) 發報告時間: 2016/01/03 23:59 cardiomegaly. increased infiltration in the bilateral lower lung fields. bilateral sharp costophrenic angles. post-operative change with metallic wires at sternum. placement of a NG tube. 
病理報告(Pathology Report) 
088/03/09 S9903367
Kidney,? side,needle biopsy,membranous glomerulonephritis stage II, 
臆斷(Tentative Diagnosis) 
1. Acute right side weakness, suspect recurrent left side stroke, onset 2016/2/1 (around 6-10 PM)
2. Recurrent stroke at left pariventricular white matter and right cerebellum, onset time suspect 2016/1/22
3. Ischemic stroke at right paramedian pons on 2015/12/29, with dysarthria and right hemiparesis, under bokey+plavix, changed to plavix + pletaal on 2016/1/15 
4. Suspect acute on chronic heart failure (LVEF 59%, ProBNP 20000)
5. Multifocal atrial tachycardia, under Verapamil rate control
6. Acute on Chronic kidney injury, suspect due to occult infection, peritonitis or UTI can't be excluded
7. Hepatitis C, with massive ascites; Child-Pugh score B
8. Hypertension for 10+ years, under medication control 
9. Type 2 diabetes mellitus for 10+ years, under medication control
10. Left lower limb status post above knee amputation  due to peripheral arterial occlusive disease in 2012/2 
11. Old infarctions at left posteior frontal and parietal cortical/subcortical regions (2013 MRI)
12. IHCA status post CPR and ECMO due to cardiovascular disease(3-vessel-disease with NSTEMI), status post CABG on 2011/12/28
13. Dry gangrene in 4th toe due to peripheral arterial occlusive disease 
醫療需求與治療計畫(Medical Needs and Care Plan) 
#1. Recurrent stroke on 2016/02/01
A:
Conscious drowsy now with NG use
Decreased muscle power in RUE
Under Plavix and Pletaal use
P:
1. Arrange Brain CT/MRI again later.
2. Pursue holter report: Afib or MAT.
3. Consider resume aspirin + Plavix after rule out large stroke.
4. Keep N/S hydration, 1000ml/day, carefully monitor I/O and respiratory pattern

#2. Ascites
A:
r/o Liver cirrhosis, Anti-HCV (+)
r/o Peritonitis, SBP?
Pending ascited culture
Alb: 1/29 2.0 -->1/31 2.1 (Albumin supplement 1/30~2/1)
Abdomen : soft, mild distension, no tenderness
Abdomen CT: Increased ascites and mesenteric fat stranding, more severe at upper abdomen, peritonitis can't be excluded
P:
1. Arrange abdomen echo
2. Check albumin, supplement if needed

#3. CHF, CAD 3VD, AKI on CKD, DM
heart echo: LVEF:55%
tachypnea may related acidosis
Proteinuria, r/o nephrotic syndrome
Hypokalemia, high TTKG: 9.64, r/o HTN, r/o hypomagnesium, r/o acidosis related
Hypomagnesium-> hypermagnesium, r/o over supplement
P:
1. monitor I/O, follow up VBG, electrolytes
2. avoid nephrotoxicity medication, discussed with family for H/D risk

Treatment Goal: no fever, pain<3, stable neurological status 
出院規劃(Discharge Planning) 
管路留置狀況:有
靜脈管路留置(含Hickman / Port-A)：有 右頸 右腹股溝 
雙腔導管留置：無  
鼻胃管留置：有 16Fr. 
氣管管路留置：無    
胃造廔口：無  
尿管留置：有 Two way Foley 14Fr. 
膀胱造廔：無 
傷口引流管：無
其他導管：
日常生活功能分數：5
預期出院後居住場所：與家人同住 
預期出院後主要照顧者：配偶 外勞 
出院規劃收案篩檢：高危病患 帶有管路 功能量表未滿60分 
主治醫師評論(VS Comments) 
I agree with the assessment of the resident. 
醫師姓名 
林坤霈 主治醫師 
